Our computational sciences department has decades of experience and plays a pivotal role in many drug discovery projects. There is close collaboration between Sygnature’s computational scientists and medicinal chemists, and the clients scientific team. Our computational scientists support drug discovery projects during target analysis, hit identification, hit to lead and lead optimisation. Sygnature also offers computational chemistry as a stand-alone capability, such as in silico based virtual high-throughput screening (vHTS), or supporting drug discovery activities elsewhere.
Senior Scientists in DMPK
Commercial Contracts Manager